Cutaneous and ocular toxicology · 2026
Preclinical safety evaluation of subconjunctival methotrexate in the rabbit model.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Savla Raj, Malani Manisha, Basu Soumyava, Nirmal Jayabalan
Аннотация
PURPOSE: To assess the safety of subconjunctival methotrexate in New Zealand White rabbits.
METHODS: The New Zealand white rabbits received subconjunctival injections of methotrexate in the right eye with amounts of 400, 800, 1600, and 3200 μg. Slit lamp biomicroscopy and corneal fluorescein staining were used to assess the anterior segment of the eye. Vitreous haze and fundus abnormalities were evaluated using slit lamp indirect ophthalmoscopy. The intraocular pressure was measured using a rebound tonometer. After 30 days of methotrexate administration, the rabbits were sacrificed, and their eyeballs were enucleated for histological analysis.
RESULTS: Upon examination, no obvious changes were observed in the anterior and posterior segments of the eye. The intraocular pressure levels of the injected eye, prior to and after injections, did not show any significant difference. Furthermore, the ocular tissue displayed no signs of histological alterations.
CONCLUSION: Methotrexate injected via the subconjunctival route (up to 3200 μg) was found to be safe and well-tolerated in the rabbit model. However, future investigations are required to assess the pharmacokinetics and therapeutic efficacy in the disease-specific animal model.
METHODS: The New Zealand white rabbits received subconjunctival injections of methotrexate in the right eye with amounts of 400, 800, 1600, and 3200 μg. Slit lamp biomicroscopy and corneal fluorescein staining were used to assess the anterior segment of the eye. Vitreous haze and fundus abnormalities were evaluated using slit lamp indirect ophthalmoscopy. The intraocular pressure was measured using a rebound tonometer. After 30 days of methotrexate administration, the rabbits were sacrificed, and their eyeballs were enucleated for histological analysis.
RESULTS: Upon examination, no obvious changes were observed in the anterior and posterior segments of the eye. The intraocular pressure levels of the injected eye, prior to and after injections, did not show any significant difference. Furthermore, the ocular tissue displayed no signs of histological alterations.
CONCLUSION: Methotrexate injected via the subconjunctival route (up to 3200 μg) was found to be safe and well-tolerated in the rabbit model. However, future investigations are required to assess the pharmacokinetics and therapeutic efficacy in the disease-specific animal model.